top of page
The #JPM16 Naughty or Nice List

Updated each day through January 11, 2016

It's nearing that time of year again when the Super Bowl of healthcare investing takes place in San Francisco at the J.P. Morgan Healthcare Conference (January 11-14 for 2016). For those institutional investors able to secure a golden ticket to attend, nothing quite beats it. While that is great for them, it often puts everyone else at a disadvantage.

 

Last year was the start of a movement to make JPM more transparent and fair by encouraging companies to webcast their breakout room Q&A sessions. Breakout rooms take place after a company's main presentation, and this is where a lot of the good information is discussed. However, these highly-relevant sessions had almost never been webcast in the past. That's not fair to those on the outside, so many brought it up with the companies directly last year.

 

Thanks to the awareness movement, which was kindly amplified by Adam Feuerstein at TheStreet.com here and Meg Tirrell at CNBC here, over 50 companies ultimately chose to webcast their breakout room in 2015 (most for the first time ever). This is important because it put the webcast issue on many people's radar for the first time, but also keep in mind that over 300 companies present at the conference.

 

While 2015 was a great start, we want the numbers for 2016 to be even better. As companies announce their upcoming participation at this year's conference, I am keeping track below of which ones do (nice) and do not (naughty) elect to webcast their breakout room Q&A. I will update the list as companies clarify their intention, so please let me know of any changes as you are aware of them. 

 

Here is the current list of companies confirmed to be naughty or nice at this year's J.P. Morgan Healthcare Conference:

85

Acadia Pharma

Aegerion Pharma

Agios Pharmaceuticals

Aimmune Therapeutics

Albany Molecular Res.

Alder Biopharma

Alexion

Alkermes

Alnylam

AMAG Pharmaceuticals

Amedisys

AmerisourceBergen

Amicus Therapeutics

Amgen

AMN Healthcare

athenahealth

Baxalta

Baxter

Biogen

bluebird bio

Boston Scientific

Cardinal Health

Cellectis

Celgene

Charles River Labs

Clovis Onoclogy

Emergent BioSolutions

Enanta Pharmaceuticals

Exact Sciences
Foundation Medicine

Global Blood Therapeutics

Halyard Health

HCA

HealthSouth

Healthways

HeartWare

Hill-Rom

Horizon Pharma

Infinity Pharma

Illumina

ImmunoGen

Imprivata

Insmed

Insulet Corporation

Insys Therapeutics

Intersect ENT

Invitae

Ironwood Pharma

Johnson & Johnson

Juno Therapeutics

Karyopharm

Keryx

LabCorp of America

Magellan Health

Mallinckrodt

Mannkind

McKesson Corporation

Medivation

Molecular Partners

Molina Healthcare

Momenta Pharma

Nektar Therapeutics

NeuroDerm

Novadaq Technologies

Ophthotech Corp

Orthofix International

Otonomy

Penumbra

Premiere, Inc.

Qiagen

Quotient

Regeneron

Sage Therapeutics

Seattle Genetics

Seres Therapeutics

Shire plc

Stryker

Takeda

TeamHealth

United Therapeutics

Ventas

WebMD

Wright Medical

Zimmer Biomet

Ziopharm

Zoetis

 

188

Abaxis

Abbott Labs

Abiomed

AbbVie

Acadia Healthcare

Accelerate Diagnostics

Accuray

Acorda Therapeutics

Aduro Biotech

The Advisory Board

Aetna

Affymetrix

Agilent Technologies

Alere

Alexandria Real Estate

Allscripts Healthcare

Almost Family

Amsurg

AngioDynamics

Antares Pharma

Anthem

Arena Pharma

Array BioPharma

AstraZeneca

Atara Biotherapeutics

aTyr Pharma

Bayer

Becton Dickinson

BioCryst Pharma

BioMarin Pharma

Bio-Rad Laboratories

Bio-Techne

Bristol-Myers Squibb

Bruker Corporation

Cantel Medical

Catalent

Cempra

Centene Corporation

Cepheid

Cerner

Chemed Corp

ChemoCentryx

Chimerix

Cigna

Coherus BioSciences

Communithy Health

ConforMIS

ConMed Corporation

Connecture

The Cooper Companies

C.R. Bard

CSL Limited

CVS Health

Danaher

Dexcom

Diplomat Pharma

Dynavax Technologies

Eagle Pharmaceuticals

Edwards Lifesciences

EndoChoice

Endo International

Endologix

Envision Healthcare

Esperion Therapeutics

Everyday Health

Evolent Health

Express Scripts

FEI Company

Five Prime Therapeutics

GenMark Diagnostics

Genomic Health

Gilead Sciences

Glaukos

GlaxoSmithKline

Globus Medical

Halozyme

HCP, Inc.

HealthEquity

Henry Schein

HMS Holdings

Hologic

ICON plc

ICU Medical

IDEXX Labs

Ignyta

Impax Laboratories

INC Research

Incyte

Inogen

Inovaion

Integra LifeSciences

Intra-Cellular Therapies

Intrexon

Intuitive Surgical

Ionis Pharma

Jazz Pharma

Kindred Healthcare

Kite PHarma

Lexicon Pharma

LHC Group

LifePoint Health

Lilly

Luminex

Masimo

The Medicines Company

Medidata Solutions

MEDNAX

Medtronic

Merck & Co.

Merck KGaA

Merrimack

Mesoblast

Mettler-Toledo

MiMedx

Model N

Mylan

Myriad Genetics

NanoString Tech

Natus Medical

Neurocrine Biosciences

Nevro Corp

Novartis

Novavax

Novocure

Novozymes

NuVasive

OncoMed Pharma

OPKO Health

Orexigen

OvaScience

Owens & Minor

Oxford Immunotec

Pacific Biosciences

Pacira

PAREXEL International

Patterson Companies

PerkinElmer

Perrigo

Pfizer/Allergan

ProNAi Therapeutics

PTC Therapeutics

Puma Biotechnology

Quality Systems

Quest Diagnostics

Quidel Corporation

Radius Health

ResMed

Rigel Pharmaceuticals

Roche

Sagent Pharma

Sangamo

Sanofi

Santen

Select Medical

Sequenom

Spark Therapeutics

Spectranetics

St. Jude Medical

Stemline Therapeutics

Surgery Partners

Surgical Care Affiliates

T2 Biosystems

Teladoc

Teleflex

Tenet Healthcare

Teva

TG Therapeutics

Thermo Fisher Scientific

TransEnterix

Ultragenyx

Universal American

Universal Health Svcs

Valeant

Varian Medical Systems

Veeva System

Veracyte

Vertex Pharma

Vocera Communications

VWR

Walgreens

Waters Corp

WellCare Health Plans

Welltower

West Pharma Svcs

Zeltiq Aesthetics

3M Company

 

Who Am I?
Brad Loncar

I'm an individual investor from Kansas City.  My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>

More on the web
Follow Me
  • Twitter App Icon
  • Stocktwits.jpg
  • YouTube Classic
  • Google+ Classic
bottom of page